Clinical Characteristics and Outcomes in Patients With Coronavirus Disease 2019 and Multiple Sclerosis

JAMA Neurology - Tập 77 Số 9 - Trang 1079 - 2020
Céline Louapre1, Nicolas Collongues2, Bruno Stankoff3,1, Claire Giannesini4, Caroline Papeix1, Caroline Bensa5, Romain Deschamps5, Alain Créange6, Abir Wahab6, Jean Pelletier7, Olivier Heinzlef8, Pierre Labauge9, Laurent Guilloton10, Richard Perry11, Mathilde Goudot12, Kévin Bigaut2, Sandra Vukusic13, Catherine Lubetzki1, H. Devilliers2
1Institut du Cerveau et de la Moelle Épinière, Assistance Publique des Hôpitaux de Paris, Hôpital de la Pitié Salpêtrière, Sorbonne Université, Institut National de la Santé et de la Recherche Médicale, Centre National de la Recherche Scientifique, Clinical Investigation Center Neuroscience, Paris, France
2Service de Neurologie, Clinical Investigation Center Institut National de la Santé et de la Recherche Médicale 1434, Centre Hospitalier Universitaire de Strasbourg, Strasbourg, France
3Hôpital St Antoine, Assistance Publique des Hôpitaux de Paris, Paris, France
4CHU Saint-Antoine [AP-HP] (184, rue du Faubourg Saint-Antoine 75571 Paris cedex 12 - France)
5Département de Neurologie, Hôpital Fondation Adolphe de Rothschild, Paris, France
6Service de Neurologie, Centre de Ressources et de Compétences–Sclérose en Plaques, Assistance Publique des Hôpitaux de Paris, Groupe Hospitalier Henri Mondor, Université Paris-Est Créteil, Créteil, France
7Service de Neurologie, Pôle de Neurosciences Cliniques, Assistance Publique–Hôpitaux de Marseille, Hôpital de la Timone, Aix Marseille Université, Marseille, France
8Centre hospitalier intercommunal de Poissy/Saint-Germain-en-Laye - CHIPS [Poissy] (Site de Poissy 10 rue du Champ Gaillard - Poissy Site de Saint-Germain-en-Laye 20 rue Armagis - Saint-Germain-en-Laye - France)
9Département de Neurologie, Centre Hospitalier Universitaire de Montpellier, Montpellier, France
10Association des Neurologues Libéraux de Langue Française, Bergerac, France
11Département de Neurologie, Hôpitaux Civils de Colmar, Colmar, France
12Service de Neurologie, Groupe Hospitalier de la Region de Mulhouse, Mulhouse, France
13Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, Lyon/Bron, France

Tóm tắt

Từ khóa


Tài liệu tham khảo

Zhou, 2020, Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study., Lancet, 395, 1054, 10.1016/S0140-6736(20)30566-3

Brownlee, 2020, Treating multiple sclerosis and neuromyelitis optica spectrum disorder during the COVID-19 pandemic., Neurology, 94, 949, 10.1212/WNL.0000000000009507

Giovannoni, 2020, The COVID-19 pandemic and the use of MS disease-modifying therapies., Mult Scler Relat Disord, 39, 10.1016/j.msard.2020.102073

Cao, 2020, A trial of lopinavir-ritonavir in adults hospitalized with severe COVID-19., N Engl J Med, 382, 1787, 10.1056/NEJMoa2001282

Salje, 2020, Estimating the burden of SARS-CoV-2 in France., Science, 10.1126/science.abc3517

Wu, 2020, Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China., JAMA Intern Med, 10.1001/jamainternmed.2020.0994

Yan, 2020, Self-reported olfactory loss associates with outpatient clinical course in COVID-19., Int Forum Allergy Rhinol, 10.1002/alr.22592

Richardson, 2020, Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area., JAMA, 10.1001/jama.2020.6775

Louapre, 2020, Patients with MS treated with immunosuppressive agents: across the COVID-19 spectrum., Rev Neurol (Paris), 176, 523, 10.1016/j.neurol.2020.04.009

Novi, 2020, COVID-19 in a MS patient treated with ocrelizumab: does immunosuppression have a protective role?, Mult Scler Relat Disord, 42, 10.1016/j.msard.2020.102120

Stokmaier, 2018, Effect of ocrelizumab on vaccine responses in patients with multiple sclerosis., Neurology, 90

Chen, 2020, Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study., Lancet, 395, 507, 10.1016/S0140-6736(20)30211-7

Zheng, 2020, Letter to the editor: obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease., Metabolism, 108, 10.1016/j.metabol.2020.154244

Levy, 2017, Respiratory impairment in multiple sclerosis: a study of respiratory function in wheelchair-bound patients., Eur J Neurol, 24, 497, 10.1111/ene.2017.24.issue-3

Verity, 2020, Estimates of the severity of coronavirus disease 2019: a model-based analysis., Lancet Infect Dis, 20, 669, 10.1016/S1473-3099(20)30243-7

Gianfrancesco, 2020, Rheumatic disease and COVID-19: initial data from the COVID-19 Global Rheumatology Alliance provider registries., Lancet Rheumatol, 2, E250, 10.1016/S2665-9913(20)30095-3

Multiple Sclerosis International Federation. The coronavirus and MS—updated global advice. Published April 13, 2020. Updated June 18, 2020. Accessed June 19, 2020. https://www.msif.org/news/2020/02/10/the-coronavirus-and-ms-what-you-need-to-know/.

Thông tin
Thông tin xuất bản

JAMA Neurology

Tập 77 Số 9

1079

Thông tin tác giả